ArticleResearch and practice in thrombosis and haemostasis2024

Real-world usage and effectiveness of recombinant factor VIII/factor IX Fc in hemophilia A/B: final data from the 24-month, prospective, noninterventional PREVENT study in Germany.

Christoph Bidlingmaier et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.